Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tessenderlo Group is planning to sell its pharmaceutical ingredients plants, Farchemia and Calaire Chimie to International Chemical Investors Group.
Subscribe to our email newsletter
The employee representatives of Farchemia in Italy and Calaire Chimie in France have been informed regarding the launch of consultation procedures, according to Tessenderlo.
Tessenderlo by divesting intends to strengthen its specialty products and services in the areas of food, agriculture, water management and valorizing bio-residuals.
Tessenderlo’s pharma business unit supplies intermediates and active pharmaceutical ingredients for international pharmaceutical companies, both for the branded and the generic markets.